Clinical Trials Logo

Clinical Trial Summary

Phase 1 randomized, double-blind, three period, crossover study comparing the pharmacodynamic, pharmacokinetic, safety and tolerability profiles for Arecor ultra-rapid insulin aspart (AT247), NovoLog® and Fiasp® in participants with type 1 diabetes mellitus (T1DM) during continuous subcutaneous infusion (CSII)

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05184868
Study type Interventional
Source Arecor Limited
Status Not yet recruiting
Phase Phase 1
Start date January 2022
Completion date September 2022

See also
  Status Clinical Trial Phase
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT03605329 - Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Active, not recruiting NCT05107544 - Metabolic Effect of High Intensity Interval Training (HIIT) in Adolescents With Type 1 Diabetes N/A
Recruiting NCT04443153 - Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes N/A
Recruiting NCT04521634 - Glycaemic Variability in Acute Stroke
Completed NCT04569994 - A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes Phase 1
Completed NCT04089462 - Effects of Frequency and Duration of Exercise in People With Type 1 Diabetes A Randomized Crossover Study N/A
Active, not recruiting NCT03143816 - Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study—STAT Study Phase 4
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A
Completed NCT04042207 - Diabeloop for Highly Unstable Type 1 Diabetes N/A
Recruiting NCT04974528 - Afrezza® INHALE-1 Study in Pediatrics Phase 3
Recruiting NCT03988764 - Monogenic Diabetes Misdiagnosed as Type 1
Not yet recruiting NCT04304963 - Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS
Recruiting NCT03682640 - Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes Phase 2
Withdrawn NCT03242005 - The PSIQS Study - User Experience With Pro-Set N/A
Recruiting NCT02953249 - Wound Healing After Tooth Extraction in Individuals With Type 1 Diabetes Mellitus N/A
Completed NCT02839174 - Type One Diabetes and Low Carb Study N/A
Completed NCT02411578 - Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia Phase 2